Farmers Edge Inc Ordinary Shares Stock (OTC: FMEGF)

Farmers Edge Inc Ordinary Shares Stock (OTC:FMEGF), Trade Ideas

Farmers Edge Inc Ordinary Shares

News

Guidance

VSEC

VSE Corporation Raises Aviation Segment Revenue Growth Guidance Range From 24-28% To 34-38%, Decreases Fleet Segment Revenue Growth Guidance Range From 13-17% To 0-5%

PIII

P3 Health Partners Sees FY24 Revenue $1.450B-$1.550B Vs $1.495B Est.

Invesco Mortgage Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVR#NYSE">IVR</a>) reported quarterly earnings of $0.86 per share which missed the analyst consensus estimate of $1.14 by 24.56 percent. This is a 42.67 percent decrease over earnings of $1.50 per share from the same period last year. The company reported quarterly sales of $52.29 million which missed the analyst consensus estimate of $59.56 million by 12.21 percent. This is a 24.80 percent decrease over sales of $69.53 million the same period last year.

Earnings

Earnings Misses

Invesco Mortgage Capital Q1 Adj $0.86 Misses $1.14 Estimate, Sales $52.29M Miss $59.56M Estimate

Portman Ridge Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTMN#NASDAQ">PTMN</a>) reported quarterly earnings of $0.67 per share which missed the analyst consensus estimate of $0.72 by 6.94 percent. This is a 24.72 percent decrease over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $16.526 million which missed the analyst consensus estimate of $17.716 million by 6.72 percent. This is a 18.70 percent decrease over sales of $20.327 million the same period last year.

PTMN

Portman Ridge Finance Q1 2024 GAAP EPS $0.67 Misses $0.72 Estimate, Sales $16.526M Miss $17.716M Estimate

LPSN

LivePerson Sees Q2 2024 Revenue $76M-$80M Vs $76.648M Est.

Orion Office REIT Reaffirms 2024 Core FFO Outlook Of $0.91-$1.01

Ashford (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AINC#AMEX">AINC</a>) reported quarterly earnings of $1.99 per share. This is a 19.16 percent increase over earnings of $1.67 per share from the same period last year. The company reported quarterly sales of $209.134 million which beat the analyst consensus estimate of $199.700 million by 4.72 percent. This is a 12.97 percent increase over sales of $185.122 million the same period last year.

Earnings Beats

AINC

Ashford Q1 2024 GAAP EPS $1.99 Up From $1.67 YoY, Sales $209.134M Beat $199.700M Estimate

NextNav (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NN#NASDAQ">NN</a>) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.14) by 100 percent. This is a 86.67 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.046 million which missed the analyst consensus estimate of $1.220 million by 14.26 percent. This is a 26.02 percent increase over sales of $830.000 thousand the same period last year.

NextNav Q1 2024 GAAP EPS $(0.28) Misses $(0.14) Estimate, Sales $1.046M Miss $1.220M Estimate

Business Outlook
For the second quarter of 2024, the company expects revenues to range between $2.148 and $2.168 billion, an increase of approximately 1 - 2% over the previous quarter, or a normalized and constant currency increase of 2 - 3% excluding the quarter-over-quarter impact of the power pass-through. This guidance includes a $7 million negative foreign currency impact when compared to the average FX rates in Q1 2024. Adjusted EBITDA is expected to range between $1.019 and $1.039 billion. This guidance includes a $4 million negative foreign currency impact when compared to the average FX rates in Q1 2024 and $6 million of integration costs from acquisitions. Recurring capital expenditures are expected to range between $38 and $58 million.
For the full year of 2024, total revenues are expected to range between $8.692 and $8.792 billion, a 6 - 7% increase over the previous year, or a normalized and constant currency increase of 7 - 8% excluding the year-over-year impact of the power pass-through. This updated guidance maintains prior full year revenue guidance, offset by a $101 million negative foreign currency impact when compared to the prior guidance rates. Adjusted EBITDA is expected to range between $4.044 and $4.124 billion, an adjusted EBITDA margin of 47%. This updated guidance includes a full year adjusted EBITDA raise of $5 million, offset by a $50 million negative foreign currency impact when compared to prior guidance rates. AFFO is expected to range between $3.290 and $3.370 billion, an increase of 9 - 12% over the previous year, or a normalized and constant currency increase of 10 - 13%. This updated guidance includes an underlying raise of $25 million from lower net interest expense and lower integration costs, offset by a $36 million negative foreign currency impact when compared to prior guidance rates. AFFO per share is expected to range between $34.45 and $35.29, an increase of 7 - 10% over the previous year, or a normalized and constant currency increase of 8 - 11%. Total capital expenditures are expected to range between $2.780 and $3.030 billion. Non-recurring capital expenditures, including xScale-related capital expenditures, are expected to range between $2.570 and $2.800 billion, and recurring capital expenditures are expected to range between $210 and $230 million. xScale-related on-balance sheet capital expenditures are expected to range between $12 and $52 million, which we anticipate will be reimbursed to Equinix from both the current and future xScale JVs.
The U.S. dollar exchange rates used for 2024 guidance, taking into consideration the impact of our current foreign currency hedges, have been updated to $1.10 to the Euro, $1.27 to the Pound, S$1.35 to the U.S. Dollar, ¥151 to the U.S. Dollar, A$1.53 to the U.S. Dollar, HK$7.83 to the U.S. Dollar, R$5.01 to the U.S. Dollar and C$1.35 to the U.S. Dollar. The Q1 2024 global revenue breakdown by currency for the Euro, British Pound, Singapore Dollar, Japanese Yen, Australian Dollar, Hong Kong Dollar, Brazilian Real and Canadian Dollar is 20%, 10%, 8%, 6%, 4%, 3%, 3% and 2%, respectively.
The adjusted EBITDA guidance is based on the revenue guidance less our expectations of cash cost of revenues and cash operating expenses. The AFFO guidance is based on the adjusted EBITDA guidance less our expectations of net interest expense, an installation revenue adjustment, a straight-line rent expense adjustment, a contract cost adjustment, amortization of deferred financing costs and debt discounts and premiums, income tax expense, an income tax expense adjustment, recurring capital expenditures, other income (expense), (gains) losses on disposition of real estate property, and adjustments for unconsolidated joint ventures' and non-controlling interests' share of these items.

EQIX

For Q2 2024, Expects Revenues To Range Between $2.148B-$2.168B Vs $2.18B Est.; FY24 Revenue $8.692B-$8.792B Vs $8.86B Est.

STKL

SunOpta Raises FY24 Revenue Forecast From $670M-$700M To $685M-$715M (Est $679.949M)

Watts Water Technologies Raises 2024 Organic Sales Growth By 50 bps (4%)-1%

TTEC Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEC#NASDAQ">TTEC</a>) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.30 by 10 percent. This is a 65.38 percent decrease over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $576.638 million which beat the analyst consensus estimate of $564.413 million by 2.17 percent. This is a 8.95 percent decrease over sales of $633.286 million the same period last year.

TTEC

TTEC Holdings Q1 2024 Adj EPS $0.27 Misses $0.30 Estimate, Sales $576.638M Beat $564.413M Estimate

ZoomInfo Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NYSE">ZI</a>) shares traded lower on Wednesday after the company reported first-quarter financial results and issued second-quarter <a href="https://www.benzinga.com/pressreleases/24/05/b38681355/zoominfo-announces-first-quarter-2024-financial-results">guidance below estimates</a>.
What To Know: ZoomInfo Technologies reported first-quarter 2024 adjusted earnings per share (EPS) of 26 cents, exceeding the consensus estimate of 23 cents by 13.04%. The company&#8217;s quarterly revenue stood at $310.1 million, surpassing the analyst consensus estimate of $308.74 million by 0.44%. 
Looking ahead, ZoomInfo provided guidance for the second quarter and full-year 2024. 
The company expects second-quarter EPS to be in the range of 23 cents to 24 cents, versus estimates of 25 cents per share. Second-quarter revenue is projected to be between $306 million and $309 million, versus estimates of $313.11 million.
For the full year, ZoomInfo raised its EPS outlook from a range of 99 cents to $1.01 to a new range of $1 to $1.02, versus estimates of $1. The company expects full-year revenue to be between $1.255 billion and $1.27 billion, versus estimates of $1.27 billion.
Despite the positive earnings report, concerns about the company&#8217;s future financial performance appears to have led to a notable decline in its share price.
Analysts React: Following the company&#8217;s first-quarter 2024 earnings report, analysts across various firms adjusted their price targets. Wells Fargo, Needham, UBS and Stifel maintained their ratings but <a href="https://www.benzinga.com/analyst-stock-ratings">lowered their price targets</a>, while Piper Sandler, Mizuho and Goldman Sachs downgraded ZoomInfo and adjusted their targets accordingly.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38710580/zoominfo-technologies-stock-dives-on-heels-of-q1-earnings-investors-need-to-careful">ZoomInfo Technologies Stock Dives On Heels Of Q1 Earnings: &#8216;Investors Need To Carefully Monitor The Macro&#8217;</a>
ZI Price Action: ZoomInfo shares closed Wednesday down 24.2% at $12.15, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro. </a>
Image: Pixabay.

Movers

ZoomInfo Technologies Stock Plunges After Q1 Earnings: What You Need To Know

Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) reported quarterly earnings of $8.86 per share which beat the analyst consensus estimate of $8.64 by 2.55 percent. This is a 3.14 percent increase over earnings of $8.59 per share from the same period last year. The company reported quarterly sales of $2.13 billion which missed the analyst consensus estimate of $2.14 billion by 0.61 percent. This is a 6.46 percent increase over sales of $2.00 billion the same period last year.

Equinix Q1 FFO $8.86 Beats $8.64 Estimate, Sales $2.13B Miss $2.14B Estimate

DXPE

DXP Enterprises Sees Q1 2024 Adj. EPS $0.74 Down From $0.95 YoY; Revenue $412.6M Down From $424.3M YoY

Pennant Park Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNNT#NYSE">PNNT</a>) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.24 by 8.33 percent. This is a 15.38 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $35.979 million which missed the analyst consensus estimate of $36.336 million by 0.98 percent. This is a 1.02 percent decrease over sales of $36.349 million the same period last year.

PNNT

Pennant Park Investment Q2 2024 GAAP EPS $0.22 Misses $0.24 Estimate, Sales $35.979M Miss $36.336M Estimate

HLIO

Helios Technologies Affirms FY24 Outlook For Total Net Sales Of $840M-$860M (Est $845.448M), Adj EPS Of $2.35  -$2.75 (Est 2.44)

VSTO

Vista Outdoor Sees FY25 EPS $3.60-$4.50 vs $3.85 Est., Sales $2.665B-$2.775B vs $2.75B Est.

Appoints Luke Sarsfield to Chairman, Effective in June &nbsp;
Improves Governance Policy Through Termination of Stockholder Rights Plan
DALLAS, May 08, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=UuabUkrqbYFZTU5KY-Owuut23Yc6iZyQAIWmxGJaelezgi3mvKhRMJLUxsDh735e6MjD4ElRQVvmF0Ji8g0ZiQ==">P10, Inc.</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) (the "Company"), a leading private markets solutions provider,&nbsp;today announced several enhancements to its governance structure and policy.
Robert Alpert informed the P10 Board of Directors (the "Board") of his decision to step down as Executive Chairman, effective June 14, 2024, concurrent with the P10 Annual Meeting. Mr. Alpert will continue to serve on the Board as a director.
Additionally, the Board voted to appoint Luke Sarsfield to the role of Chairman of the Board, also effective June 14, 2024, and intends to appoint a Lead Independent Director at the P10 Annual Meeting.
"I want to thank Robert for his time as Executive Chair and look forward to our continued work on the Board," said Luke Sarsfield, P10 Chief Executive Officer. "Robert's role as Executive Chairman was intended to help me, and our senior team effect a successful leadership transition, and he now feels that transition is complete. He will continue to serve on the board as a director. I'm excited to step into this role as I work with our Board and management team to execute our strategic initiatives and advance alignment across our strategies."
The Company's Board also determined that its stockholder rights plan is no longer necessary for the preservation of federal income tax benefits and unanimously voted to terminate the rights plan effective as of the close of business on May 8, 2024.
The stockholder rights plan, which was previously set to expire in October 2024, was intended to help preserve the value of certain income tax assets, primarily tax net operating loss carryforwards. Stockholders do not have to take any action as a result of this termination.
These updates come in short succession after the previously announced appointment of Tracey Benford as an independent Class II director in April. Ms. Benford serves on the Company's Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.

Management

P10 Appoints Luke Sarsfield To Chairman, Effective June 14, 2024; Announces Termination Of Stockholder Rights Plan

Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.38) by 39.47 percent. This is a 42.5 percent increase over losses of $(0.40) per share from the same period last year.

CNTX

Context Therapeutics Q1 EPS $(0.23) Beats $(0.38) Estimate

Farmers Edge Inc. GAAP EPS of -$0.44, revenue of $6.29M

Farmers Edge GAAP EPS of -$0.44, revenue of $5.18M

Farmers Edge Inc. GAAP EPS of -$0.43, revenue of $4.43M beats by $0.29M

Farmers Edge announces increase in credit facility

Fairfax Financial (Prem Watsa) 2023 Letter To Shareholders

ATUSF

CIBEY

CMGGF

CSCO

EGFEF

EGFEY

EXCE

FAXRF

FAXXF

FFHPF

FFXDF

FFXXF

FMCXF

FMEGF

FRFFF

FRFGF

FRFHF

FRFXF

FRFZF

FXFHF

FXFLF

HZNOF

KODK

NVDA

ORLA

STZHF

Farmers Edge

National Bank Of Canada